Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Clin Pharmacol Ther. 2010 Feb 17;88(2):204–213. doi: 10.1038/clpt.2009.260

Figure 4.

Figure 4

Neuropathological analysis of samples from tumor-bearing Lewis rats treated with HC-Ads. Neuropathological analysis of the brains of rats at 5 days after intratumoral administration of escalating doses of HC-Ad-TetOn-Flt3L and HC-Ad-TK. Flt3L, fms-like tyrosine kinase ligand 3; MBP, myelin basic protein; MHC II, major histocompatibility complex II; TH, tyrosine hydroxilase; TK, thymidine kinase.